-
Benzinga's Top Pre-Market NASDAQ Losers
Thursday, June 23, 2011 - 8:13am | 114F5 Networks Inc (NASDAQ: FFIV) dipped 3.16% to $101.50 in the pre-market session. Analysts at JP Morgan downgraded F5 Networks from “overweight” to “neutral.” GTx Inc (NASDAQ: GTXI) dropped 2.49% to $5.10 in the pre-market trading. GTXI reported that it intends to offer and sell shares of its...
-
A Peek Into The Market Before The Trading Starts
Thursday, June 23, 2011 - 7:33am | 379Pre-open movers US stock futures are lower this morning, after the Federal Reserve lowered its outlook for US economic growth. Futures on the Dow Jones Industrial Average dipped 51 points to 11,972.00 and futures on the S&P 500 stock index fell 7.10 points to 1,272.70. Nasdaq 100 futures...
-
PURE Bioscience Receives Health Canada Approval for PURE Hard Surface Disinfectant
Thursday, June 23, 2011 - 7:03am | 202PURE Bioscience, Inc. (NASDAQ: PURE) today announced that Health Canada has approved PURE™ Hard Surface disinfectant for use in food premises, hospitals and health care facilities, domestic locations and institutional and industrial premises. PURE Hard Surface has been assigned the Drug...
-
Rodman & Renshaw Provides Color on Enzo Biochem
Wednesday, June 22, 2011 - 5:53am | 138Rodman & Renshaw provided color on Enzo Biochem (NYSE: ENZ). In a research report published today, the rating agency commented on the outcome of the U.S. Supreme Court decision. In the report, Rodman & Renshaw states, "This morning, Enzo reported that the US Supreme Court has refused to...
-
AMAG Pharmaceuticals Announces Update to Feraheme Label
Tuesday, June 21, 2011 - 5:06pm | 240AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the company has updated the product label for Feraheme Injection for Intravenous use. This update is based on the U.S. Food and Drug Administration's approval of the company's Label Supplement submission, which included additional post-...
-
Luminex Corporation to Acquire EraGen Biosciences for $34M
Tuesday, June 21, 2011 - 4:05pm | 57Luminex Corporation (NASDAQ: LMNX) today announced a definitive agreement to acquire privately-held EraGen Biosciences, Inc.. Under the terms of the agreement Luminex will purchase all outstanding shares of EraGen for approximately $34 million in cash, subject to certain adjustments. The...
-
Can Genetics Gear Maker Illumina Help Investors Crack The Code For Profits?
Tuesday, June 21, 2011 - 12:30pm | 75The market correction has taken its toll on many stocks but today we're going to look at one that's holding up fairly well – so far. It's Illumina (ILMN) and it makes tools that help scientists understand the ties between genetics and disease in order to come up with better treatments. Earnings...
-
U.S. Supreme Court Declines Life Technologies Appeal Hearing in Patent Infringement Suit Brought by Enzo Biochem Claiming Substantial Damages
Tuesday, June 21, 2011 - 11:01am | 184Enzo Biochem Inc. (NYSE: ENZ) today reported that the U.S. Supreme Court has refused to hear an appeal by Life Technologies Corp., thereby enabling it to pursue its claim for substantial damages against Applera Corporation, now Life Technologies Corporation. (NASDAQ: LIFE). The Supreme Court's...
-
Compugen Announces Initial Validation of Additional B7/CD28 Protein Family Based Product Candidate
Tuesday, June 21, 2011 - 8:15am | 77Compugen Ltd. (NASDAQ: CGEN) announced today in vitro validation of a second product candidate based on Compugen-discovered novel members of the B7/CD28 co-stimulatory protein family. Proteins belonging to the B7/CD28 family are of high industry interest in view of their key roles in regulating...
-
Compugen Announces Initial Validation of Additional B7/CD28 Protein Family Based Product Candidate
Tuesday, June 21, 2011 - 8:07am | 262Compugen Ltd. (NASDAQ: CGEN) announced today in vitro validation of a second product candidate based on Compugen-discovered novel members of the B7/CD28 co-stimulatory protein family. Proteins belonging to the B7/CD28 family are of high industry interest in view of their key roles in regulating...
-
Genetic Technoligies Ltd (NASDAQ:GENE) – Imminent Launch Of Breast Cancer Test Kit?
Monday, June 20, 2011 - 4:33am | 402My last post about Genetic Technoligies Ltd (NASDAQ:GENE) was made back in January of this year. In that post, I referred to the imminent launch of their BREVAGen test kits, which test for breast cancer. Last Friday, the stock managed to rally 75c, closing at $5.67 for a 15% gain. At the time,...
-
Bears Stop for a Pic-a-Nic 06-17-2011
Friday, June 17, 2011 - 4:37pm | 981Cusick's Corner The market is now just off its best levels but for the most part we are seeing a market bounce on positive headlines and the shorts are stepping aside at this stage. Now this can be expected to happen over the next few sessions, especially since the market just was brutalized over...
-
U.S. Stocks Ease From Day's Highs; Illumina Up 2%
Friday, June 17, 2011 - 12:07pm | 74Stocks pulled back from their intraday highs Friday in midday action. The Nasdaq clung to a 0.2% gain after being up as much as 0.9%. The S&P 500 rose 0.6% and the NYSE composite added 0.8%. The defensive Dow Jones Utility Average held a 1.1% gain. Volume was up sharply across the board. Today...
-
Kendle International Increases Consideration Amount for Tender Offer and Consent Solicitation for Convertible Notes
Friday, June 17, 2011 - 9:00am | 226Kendle International Inc. (Nasdaq: KNDL) announced today that it has increased the consideration amount offered for its cash tender offer and consent solicitation for any and all of its $142.5 million aggregate principal amount of outstanding 3.375% Convertible Senior Notes due 2012. The...
-
Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates
Friday, June 17, 2011 - 12:07am | 150Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year. The earnings estimate for Laboratory Corp of America Holdings (NYSE: LH) for the next year ending December, 2012 is $7.14 per share. LH's trailing-twelve...